Quotient is an excellent example how change at the top can turn a company around. From a company missing deadlines and extended timelines, Quotient has turned into a company with clear goals and ...
Manuel O. Méndez, CEO of AliveDx: " We are thrilled to submit the MosaiQ AiPlex® CTDplus microarray to the FDA for 510 (k) clearance. With autoimmune disease diagnoses often taking more than four ...
EYSINS, Switzerland, April 3, 2025 /PRNewswire/ -- Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback